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Archaea have been isolated from the human colon, vagina, and
oral cavity, but have not been established as causes of human
disease. In this study, we reveal a relationship between the
severity of periodontal disease and the relative abundance of
archaeal small subunit ribosomal RNA genes (SSU rDNA) in the
subgingival crevice by using quantitative PCR. Furthermore, the
relative abundance of archaeal small subunit rDNA decreased at
treated sites in association with clinical improvement. Archaea
were harbored by 36% of periodontitis patients and were re-
stricted to subgingival sites with periodontal disease. The presence
of archaeal cells at these sites was confirmed by fluorescent in situ
hybridization. The archaeal community at diseased sites was dom-
inated by a Methanobrevibacter oralis-like phylotype and a distinct
Methanobrevibacter subpopulation related to archaea that inhabit
the gut of numerous animals. We hypothesize that methanogens
participate in syntrophic relationships in the subgingival crevice
that promote colonization by secondary fermenters during peri-
odontitis. Because they are potential alternative syntrophic part-
ners, our finding of larger Treponema populations sites without
archaea provides further support for this hypothesis.
Methanogenic Archaea have been isolated from the humanoral cavity (1), as well as the human gut (2) and vagina (3).
Despite their detection among the human microbiota, an asso-
ciation has not been demonstrated between severity of disease
and the relative abundance of members of the domain Archaea.
(4). The oral disease, chronic periodontitis, is a polymicrobial
infection afflicting 35% of U.S. adults (5). The disease may result
in loss of teeth and has been implicated in endocarditis, athero-
sclerosis, stroke, and preterm delivery of low-birth-weight in-
fants (6). Chronic periodontitis has been linked to multiple
members of the domain Bacteria (7); however, no one member
explains the majority of cases, nor the role of microbes in this
disease. At the same time, there is little information on the
relationship between Archaea and chronic periodontitis. Al-
though methanogenic Archaea have been found in the mouth of
patients with periodontitis, previous studies lacked fundamental
controls and were not quantitative, precluding the establishment
of a significant or clinically relevant association between Archaea
and disease (1, 8-14). The present study establishes correlations
between the presence of disease and the presence of archaeal
DNA, the severity of periodontal disease and the relative
abundance of archaeal DNA in subgingival plaque, and between
disease resolution and diminished archaeal DNA abundance.
Archaea were found to be restricted to a subset of human
subjects and to be comprised of two distinct rDNA phylotypes
within the genus Methanobrevibacter. These data have important
implications for the etiology of a disease that is exceedingly
common, and for the role of methanogens in the human micro-
bial ecosystem.
Materials and Methods
Subject Enrollment. Subjects were enrolled at the University of
California, San Francisco (UCSF), School of Dentistry in the
Ratcliff Center for Clinical Research (Division of Periodontol-
ogy). The use of human subjects in this investigation was
approved by the Stanford University Administrative Panel on
Human Subjects in Medical Research and the UCSF Committee
on Human Research. Subjects were at least 25 years old, were
missing no more than 14 teeth, had a clinical diagnosis of
generally healthy gingiva or chronic periodontitis, and were free
of other oral soft tissue disease. Periodontal status of each
subject was determined by measuring clinical attachment loss
(CAL) to the nearest millimeter at the mesiobuccal, buccal,
distobuccal, mesiolingual, lingual, and distolingual sites around
each tooth. Mean full-mouth CAL values were used to place
patients in the following categories: healthy (mean CAL 0.6
mm), slight periodontitis (0.6 mm  mean CAL 1.6 mm),
moderate periodontitis (1.6 mm  mean CAL 2.5 mm), and
severe periodontitis (mean CAL 2.5 mm; Table 1). Subjects
were excluded if they were diabetic, HIV-positive, pregnant,
lactating, or had taken antibiotics in the previous 3 months,
because these factors have been implicated in altering oral
bacterial composition. Subjects completed a survey regarding
age, gender, race, and habits of oral hygiene.
Sample Collection. Subgingival plaque samples were collected
from 6–12 periodontal pockets from each subject by using
Hartzell R-1, R-2 curettes. Supragingival plaque was removed
from tooth surfaces before sampling. Separate sterile curettes
were used for each plaque sample. Sampling included both
clinically healthy and diseased sites. Clinical assessments at each
site included the presence or absence of bleeding on probing
(BOP), probing depth (PD), and CAL. Clinical assessments and
sample collections were performed by one researcher (G.C.A.).
Each site was classified as healthy (no BOP, CAL 1 mm, PD
3 mm), having gingivitis (BOP, CAL 1 mm, PD 4 mm),
slight periodontitis (BOP, CAL 2–3 mm, and PD 4 mm),
moderate periodontitis (BOP, CAL 4–5 mm, and PD 4 mm),
or severe periodontitis (BOP, CAL 6 mm, and PD 4 mm,
Table 2). In addition, a sample was taken from the dorsum of the
tongue with a sterile plastic spatula. Less than 1 mg of plaque
material from each sampled site was placed in a 1-ml O-ring
microcentrifuge tube containing 200 l of -irradiated H2O. A
100-l aliquot was moved to another tube for fluorescent in situ
hybridization (FISH) after vortexing. The remaining aliquot was
frozen immediately and kept at80°C before further processing.
Nucleic Acids Extraction. Nucleic acids were extracted from each
100-l plaque sample by adding an equal volume of 0.1% blue
dextran (Sigma) and 2 volume of cell lysis buffer (100 mM
TrisHCl, pH 7.420 mM EDTA5 M guanidine isothiocya-
nate2% Triton X-100). Proteinase K (Sigma) was added to a
final concentration of 250 gml, and the sample was incubated
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: CAL, clinical attachment loss; FISH, fluorescence in situ hybridization; SSU,
small subunit.
Data deposition: The sequences reported in this paper have been deposited in the GenBank
database (accession nos. AY374553 and AY374554).
¶To whom correspondence should be addressed. E-mail: pwlepp@cmgm.stanford.edu.
© 2004 by The National Academy of Sciences of the USA
6176–6181  PNAS  April 20, 2004  vol. 101  no. 16 www.pnas.orgcgidoi10.1073pnas.0308766101
at 65°C for 30 min. Samples were then agitated in a FastPrep
FP120 instrument (Qbiogene, Carlsbad, CA) at 4.0 ms for 30 s
with 0.1 g each of 0.1-mm, 0.5-mm, and 1-mm diameter baked
zirconiasilica beads (Biospec, Bartlesville, OK). An equal vol-
ume of 99% benzyl alcohol was added, and the sample was
vortexed before centrifugation at 7,000  g for 5 min. The
aqueous phase was removed to a new microcentrifuge tube, and
the nucleic acids were precipitated by the addition of 110
volume 3 M NaOAc, 2 volumes 100% EtOH, and centrifugation
at 16,000  g for 30 min. Nucleic acid pellets were washed with
70% EtOH, dried in a Speedvac (Thermo Savant, Holbrook,
NY), and resuspended in 50l of -irradiated H2O. Samples that
were subsequently PCR-amplified were incubated in 20 gml
RNaseA at 37°C for 30 min. Negative lysis controls, consisting of
-irradiated water, were carried throughout the experiment.
PCR, Cloning, and Sequencing. Fragments of 16S rDNA from oral
Archaea were PCR amplified by using broad-range archaeal prim-
ers SDArch0333aS15 (5-TCCAGGCCCTACGGG-3, modified
from ref. 15) and either SDArch0958aA19 (5-YCCGGCGTT-
GAMTCCAATT-3; ref. 16) or SDArch1378aA20 (5-TGTGTG-
CAAGGAGCAGGGAC-3). Each 25-l PCR consisted of 1 l of
extracted DNA, buffer (10 mM TrisHCl, pH 8.51.5 mM
MgCl250 mM KCl200 M of each dNTP0.05% Triton X-100),
400 nM each primer, and 1.25 units of AmpliTaq (Applied Bio-
systems, Foster City, CA). Archaeal 16S rDNA genes were ampli-
fied under the following cycle conditions: 35 cycles of 94°C (30 s),
58°C (30 s), and 72°C (30 s) followed by a 3-min extension at 72°C.
Primer specificity and sensitivity were determined by using cloned
16S rDNA genes from Halobacterium salinarum (pHs16S; ATCC
33171), Sulfolobus acidocaldarius (pSc; ATCC 33909), and Esche-
richia coli Br (pEc) (17) (see Supporting Text, Table 3, and Figs.
5–7, which are published as supporting information on the PNAS
web site). PCR products of the appropriate size from patient
samples were cloned by using the TOPO-TA kit (Invitrogen) as
per manufacturer’s instructions and screened for the appropri-
ately sized inserts. Inserts were sequenced on an ABI 377 se-
quencer (Applied Biosystems, Foster City, CA) using M13(-20)F
and M13(-27)R primers for duplicate coverage with ABI PRISM
BigDye Terminators v2.0 reagents (Applied Biosystems).
Phylogenetic Analysis. Initial alignment of amplified sequences
was performed with the automated 16S rDNA sequence aligner
of the ARB software package (www.arb-home.de) against a
database of 12,569 complete and partial rRNA sequences.
Ambiguously and incorrectly aligned positions were aligned
manually on the basis of conserved primary sequence and
secondary structure. Identity matrices were generated from
either 572 or 998 masked (unambiguously aligned) positions,
depending on the primer pair used for sequence library con-
struction. Following the proposition of Kroes et al. (18), se-
quences with 99% identity were considered as a single phylo-
type. The phylogenetic associations of all representative
sequences were determined by using a maximum-likelihood
algorithm (19). These associations were confirmed by using a
parsimony algorithm (19) and a neighbor-joining algorithm (20)
of kimura two-parameter corrected evolutionary distances. Se-
quences were deposited in the GenBank database (accession
numbers AY374553 and AY374554).
FISH. Polyribonucleotide probe (polyprobe) was generated from
Microcon-100 (Millipore, Bedford, MA) purifed PCR amplicons
of cloned SBGA-1 16S rRNA that contained a T7 RNA poly-
merase promoter by using a protocol modified from that of
DeLong et al. (21). The polyprobe was transcribed by using a
modification of the manufacturer’s recommended protocol for
RNAMaxx (Stratagene). Each 25-l transcription-labeling re-
action consisted of 1 g of purified SBGA-1 amplicon, 1
transcription buffer, 30 mM DTT, 0.4 mM ATP, 0.4 mM GTP,
0.4 mM CTP, 0.8 mM UTP, 0.25 mM Cy3-UTP (Amersham
Pharmacia), 200 units of T7 RNA polymerase, balance DEPC-
H2O. Transcription reactions were incubated at 37°C for 2 h.
DNA was removed from the sample by the addition of 1DNase
buffer (200 mM TrisHCl, pH 8.420 mM MgCl2500 mM KCl),
50 units of DNaseI (Invitrogen), and 100 units of RNaseOUT
(Invitrogen) followed by a 15-min incubation at room temper-
ature. The reaction was stopped by the addition of EDTA (pH
7.2) to 2 mM final concentration and heat inactivation at 65°C
for 10 min. Polyprobe was purified with Microcon-100 columns
and subsequently hydrolyzed by the addition of MgCl2 to 30 mM
final concentration with incubation at 90°C for 10 min. Hydro-
Table 1. Vital statistics for enrolled human subjects
Healthy Slight Moderate Severe
Mean CAL, mm* 0.19  0.01 1.59 1.98  0.02 3.83  0.04
No. of patients 8 1 12 37
White 8 0 10 18
Black 0 1 1 10
Hispanic 0 0 0 7
Asian 0 0 1 2
Male 3 1 2 25
Female 5 0 10 12
Age† 43.3  13.6 34 42.6  11.7 46.0  12.2
*Mean CAL  mean full-mouth CAL  SE.
†Mean  SD.
Table 2. Vital statistics for patient samples
Periodontitis patient sample sites
Healthy controlsTongue Healthy Gingivitis Slight Moderate Severe
Samples 20 38 9 28 34 96 29
White 9 20 2 12 16 45 29
Black 6 12 5 7 14 30 0
Hispanic 2 5 0 2 4 14 0
Asian 3 1 2 7 0 7 0
Mean PD, mm* NA 3.24  0.08 4.04  0.15 4.71  0.12 6.37  0.08 8.90  0.12 1.99  0.10
Mean CAL, mm† NA 0.45  0.50 1.00 2.47  0.06 4.69  0.05 7.96  0.11 0.04  0.03
Male 12 20 7 12 14 66 11
Female 8 18 2 16 20 30 20
NA, not applicable.
*Mean PD  probing (pocket) depth  SE.
†Mean CAL  SE.









lyzation was stopped by placing the reaction on ice and adding
EDTA (pH 7.2) to a final concentration of 50 mM.
Subgingival plaque samples were vigorously vortexed for 5
min. Samples were fixed in 0.5 PBS (145 mM NaCl8.7 mM
Na2HPO41.5 mM NaH2PO4, pH 7.4) and 3.7% (wtvol) for-
malin overnight at 4°C, transferred to 4-mm-diameter Teflon
slides (Erie Scientific, Portsmouth, NH), and air dried. Samples
were dehydrated by successive passage in 50%, 80%, and 90%
EtOH for 3 min each. Ten microliters of hybridization buffer [0.9
M NaCl20 mM TrisHCl, pH 7.41% SDS1 mg/ml poly(A)
50% formamide], and 50 ng of polyprobe was added to each well.
Conditions that optimized polyprobe specificity were deter-
mined by using cloned artificial targets for FISH with a range
(0–80%) of formamide concentrations, and by using E. coli
transformed with vector but no SBGA-1 insert (22). Slides were
incubated in the dark at 65°C for 8 h in chambers humidified with
0.9 M NaCl, 20 mM TrisHCl. After hybridization, the slides were
washed in 50 ml of wash solution (70 mM NaCl20 mM TrisHCl,
pH 7.45 mM EDTA0.01% SDS) for 2 h at 45°C in the dark.
Samples were counterstained with 20 l of 5 M YOPRO-1
(Molecular Probes) for 15 min in the dark at room temperature.
Slides were rinsed with water, air dried in the dark, and mounted
with 1.7 l of Vectashield (Vector Laboratories, Burlingame,
CA). Micrographs were taken with a Bio-Rad MRC 1024ES
laser scanning confocal imaging system mounted on a Nikon
Eclipse TE300 microscope.
5 Nuclease Assay. Archaeal, bacterial, and treponemal rRNA gene
copies were quantified by using a 5 nuclease assay and an ABI
Prism 7900HT Sequence Detection System (Applied Biosystems)
(see Figs. 6–8, which are published as supporting information on
the PNAS web site). Each 10-l reaction mix consisted of 1 l of
extracted DNA, 1 TaqMan Universal PCR master mix without
AmpErase UNG (Applied Biosystems), 900 nM each primer, 200
nM probe, and 0.5 units of AmpliTaq Gold DNA polymerase
(Applied Biosystems). The cycling conditions were 95°C for 10 min,
followed by 50 cycles of 95°C for 30 s, 55°C for 30 s, 60°C for 45 s,
65°C for 15 s, and 72°C for 15 s. All probes were conjugated to a
6-carboxyfluorescein (FAM) reporter, 6-carboxy-tetramethylrho-
damine (TAMRA) quencher, and HPLC purified. The threshold
was set at 0.01, with the baseline measured from cycles 3 to 15. Total
archaeal or bacterial gene copy number was estimated for each
sample from a standard curve generated from a 10-fold serial
dilution of pHs16S or pEc16S, respectively (Supp. Figs. 6 and 7).
Archaeal small subunit (SSU) rDNA was quantified by using
primers SDArch0333aS15 and SDArch0958aA19 and probe
S*Univ0515aA19 (5-FAM-TTACCGCGGCKGCTGGGAC-
TAMRA-3; ref. 23). Bacterial SSU rDNA was quantified by using
primers SDBact0008aS20 (5-AGAGTTTGATCCTGGCTCAG-
3; ref. 23) and S*Univ0515aA19 and probe SDBact0338aS18
(5-FAM-GTCGCCTCCCGTAGGAGT-TAMRA-3; ref. 24).
Assay specificity and possible inhibition were tested with reactions
by using standard serial dilutions spiked with 1.8 ng of human DNA,
as well as Archaea-negative patient samples spiked with the archaeal
standard curve dilutions. Archaeal rDNA abundance is reported as
a percentage of total prokaryotic rRNA gene copy number [ar-
chaeal gene copy number(archaeal gene copy number bacterial
gene copy number)] to normalize for site-to-site difference in the
total abundance of biomass. Treponemal SSU rDNA was quanti-
fied by using primers SGTrep0093aS19 (5-TCTCCTAGAGYG-
GCGGACT-3) and SGTrep0767aA20 (5-TCCTGTTTGCTC-
CCCGCACY-3) in conjunction with the SDBac0338aA18 probe.
The treponemal standard curve was generated by using cloned
rDNA from ZAS-9 (25). Treponemal rDNA abundance is reported
as a percentage of total prokaryotic rRNA gene copy number.
Quantification and Statistics. As in previous work (26), we found
a greater degree of interexperimental variation than intraex-
perimental variation in measurements of sequence-specific
DNA abundance. A large portion of this variation was due to
slight differences in the slope of the real-time PCR standard
curve, which was then amplified in the conversion of log to
absolute gene copy number. To minimize interexperimental
variation, we constructed a composite standard curve that
encompassed the standard curves from all individual experi-
ments, similar to the procedure previously described (26). All
samples and standards were analyzed in duplicate within each
individual experiment. Samples with an intraexperimental co-
efficient of variation1 were reanalyzed. Significant differences
in archaeal, bacterial, and treponemal rRNA gene copy numbers
between disease states were assessed by a two-tailed, unpaired
t test. The hypothesis that the relative proportion of archaea
increased with the degree of CAL was tested by one-way
ANOVA. All errors are reported as standard error unless
otherwise specified.
Results
The subjects enrolled in this study were classified as either
possessing generally healthy gingiva or exhibiting various degrees
of periodontitis (Table 1). The mean CAL, a measure of disease
severity, in patients with severe periodontitis was significantly
higher (P  0.01) than in patients with moderate periodontitis.
The mean CAL of patients with either severe or moderate
periodontitis was significantly higher than (P  0.01) the CAL
of the healthy control population. We examined 205 subgingival
plaque samples from healthy and diseased sites, as well as 20
tongue scrapings, from 50 periodontitis patients. In addition, we
included 29 subgingival plaque samples and two tongue scrapings
from eight healthy control subjects (Table 2). To determine the
effect of conventional treatment on Archaea-positive sites, we
examined 77 posttreatment plaque samples for Archaea from
previously studied sites that had been treated with scaling and
root planing plus routine maintenance care every 3 months for
a 12- to 18-month period.
We developed a quantitative Archaea-specific SSU rDNA 5
nuclease assay to assess the relationship between the abundance
of archaeal phylotypes and disease severity. We also measured
the abundance of Bacteria-specific SSU rDNA to normalize for
variations in microbial biomass between samples, as described
(26). The Archaea- and Bacteria-specific assays had lower de-
tection limits of 100 and 1,000 gene copies, respectively (Figs. 6
and 7).
Archaeal SSU rDNA was not detected in any of the 31 samples
from the healthy control population. Archaeal SSU rDNA was
detected in 36% of the periodontitis patients. Archaeal SSU
rDNA was detected in 76.6% of periodontitis sites but was not
detected in samples from healthy sites or tongue scrapings from
Archaea-positive periodontitis patients. There was a direct cor-
relation between the relative abundance of archaeal SSU rDNA
and the severity of disease within the Archaea-positive subset of
patients (Fig. 1). Archaeal SSU rDNA accounted for 18.5 
4.2%, 7.2  2.1%, 1.3  0.7%, and 0.4  0.3% of total
prokaryotic (Bacteria plus Archaea) SSU rDNA in samples from
sites with severe periodontitis, moderate periodontitis, slight
periodontitis, and gingivitis, respectively. Although the abun-
dance of bacterial SSU rDNA increased with the severity of
periodontal disease (Fig. 2), the relative abundance of archaeal
SSU rDNA in relation to total prokaryotic SSU rDNA was
significantly higher (P 0.05) in severe and moderate periodon-
titis sites compared to slight periodontitis sites within the
Archaea-positive subset of patients. There was a significant
relationship between the degree of CAL and the relative abun-
dance of archaeal SSU rDNA (P 0.0001) within the periodon-
titis patient subpopulation. There was no discernible relationship
between ethnicity, gender, or age and the abundance of archaeal
SSU rDNA; however, the data set may have been too small to
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resolve statistically significant relationships involving these pa-
rameters.
As expected, bacterial rRNA gene copy numbers were signif-
icantly higher (P  0.001) in severely and moderately diseased
periodontitis sites compared to the healthy sites of periodontitis
patients. Similarly, the mean bacterial rRNA gene copy numbers
were significantly higher at slight periodontitis and gingivitis sites
compared to the healthy sites of periodontitis patients (P 
0.015). The mean bacterial gene copy number was significantly
lower (P  0.005) in samples from the healthy control group
(5.3 105  2.4 105 gene copies per l) compared to samples
from healthy sites in periodontitis patients (3.5 106 9.5 105
gene copies per l; Fig. 2).
The analysis of 77 samples from six patients obtained 12–18
months after treatment, and the comparison of these results with
those obtained from these sites before treatment, revealed a
significant decrease in the relative abundance of archaeal SSU
rDNA from a mean of 12.3  4.6% to 0.0056  0.0035% (P 
0.001). This decrease was accompanied by a drop in the patients’
mean CAL from 3.8  0.072 to 2.4  0.19, indicating an
improvement in disease status. The decrease in the relative
abundance of archaeal SSU rDNA was caused by a decline at
each sampled site and not caused by a reduction in prokaryotic
biomass or an increase in bacterial 16S rDNA copy number, the
latter of which remained nearly constant at 1.0 107 1.8 106
copies before treatment and 1.5  107  2.3  106 copies after
treatment (P  0.1).
To investigate the diversity of Archaea in the human subgin-
gival crevice, SSU rDNA was amplified with domain-specific
primers and cloned independently from samples collected from
six patients with periodontitis. For this purpose, we used the
same archaeal primer set as that used in the 5 nuclease assay,
and a set that amplified a larger segment of the SSU rDNA; these
primers were tested for both sensitivity and specificity (see
Supporting Text). All 105 sequenced clones fell within the genus
Methanobrevibacter of the Euryarchaea division. Phylogenetic
analysis by both maximum-likelihood and maximum parsimony
algorithms produced identical topologies (Fig. 3). Analysis using
a neighbor-joining distance method produced a topology that
differed from the other two analyses only in its placement of
Methanobrevibacter cuticularis at the root of the clade containing
Methanobrevibacter filiformis, Methanobrevibacter ruminantium,
and Methanobrevibacter arboriphilius.
The clone libraries were dominated (81% of clones) by a
phylotype (SBGA-1) with 99.8% identity to the 572 nucleotides
of Methanobrevibacter oralis available from GenBank (Fig. 3).
Using reverse primer SDArch1378aA20, we were able to extend
the sequence from what was probably Methanobrevibacter oralis
by an additional 436 nucleotides and demonstrate that this
phylotype is clearly distinguishable from Methanobrevibacter
smithii. Phylotype SBGA-1 shared 97.7% identity with M. smithii
over 998 nucleotides (positions 349-1378, E. coli numbering).
The remainder (19%) of the cloned sequences was composed of
the phylotype SBGA-2. This phylotype shared 99.8% identity
with a Methanobrevibacter sequence associated with the ciliate
Euplodinium maggi, which inhabits the ovine rumen (27, 28).
This phylotype was also closely related (99.5% identity) to, but
distinct from, the human oral ‘‘phylotype 3’’ identified by Kulik
et al. (1). Together these three phylotypes, along with phylotypes
from a number of ruminants and swine, formed a clade that
shared ancestry with M. oralis to the exclusion of M. smithii (Fig.
3). Although each of the phylotypes within this clade was
distinguishable from the others, the nucleotide differences oc-
curred in unpaired, nonhelical regions and may represent se-
quencing errors, interoperon variability, or different strains of a
single species. Phylotype SBGA-2 shared 98.6% sequence iden-
Fig. 1. Relative abundance of archaeal SSU rDNA, expressed as the mean
percent of total prokaryotic SSU rDNA in Archaea-positive patients. Error bars
represent standard error.
Fig. 2. Mean bacterial (light gray) and archaeal (dark gray) rRNA gene copy
number in periodontal health and disease. Gene copy number was deter-
mined by a quantitative 5 nuclease assay. Error bars represent standard error.
Fig. 3. Phylogenetic relationships of Archaea in the subgingival crevice
inferred from SSU rDNA analysis. Phylotypes identified in this study are shown
in bold. GenBank accession numbers for database sequences are given in
parentheses except for M. ruminantium and M. arboriphilicus, which are only
available from the Ribosomal Database Project (38). This dendrogram was
constructed from 572 homologous sequence positions (349–957, E. coli num-
bering) using a maximum-likelihood algorithm.









tity with M. oralis, but was clearly distinct at eight positions [350
(T), 560 (T), 658 (C), 747 (G), 838 (G), 848 (C), 849 (T), 850 (C);
E. coli numbering), some of which are predicted to form
compensatory base-pairing structures (658–747 and 838–848).
We used cloned SBGA-1 16S rDNA to generate an Archaea-
specific RNA polyprobe for FISH that enabled us to characterize
further the members of this domain in subgingival plaque
samples. When we used cloned artificial targets for FISH, we
found that hybridization in a solution of 50% formamide (vol
vol) at 65°C followed by a 45°C low-salt wash provided the
optimal discrimination between SBGA-1 targets and nontarget
sequences (22). These hybridization conditions were similar to
those used previously with polyribonucleotide probes (21). We
identified a population consisting primarily of diplococcobacilli
(Fig. 4) with approximate dimensions of 0.9 m  0.9 m. The
morphology and dimensions were largely consistent with those
of M. oralis (8), although the cell width observed in this study was
approximately twice that previously reported.
Methanogenesis by M. oralis is a hydrogen-consuming process.
In syntrophic relationships, this process facilitates the growth of
hydrogen-producing organisms, which include some of the
known oral bacterial pathogens. If syntrophy is an important
feature of more severely diseased periodontal pockets, one might
expect to find other syntrophic partners in methanogen-negative,
diseased sites. Treponemes are a potential hydrogen competitor,
and are a monophyletic group for which group-specific primers
can be designed. Therefore, we determined the relative abun-
dance of Treponema species rDNA within the same collection of
plaque samples as used to investigate the relative abundance of
archaeal rDNA (Fig. 8). We found that treponeme rDNA
represented 12.4  3.8% of the prokaryotic rDNA in a set of
specimens from severe and moderate periodontitis sites that had
no detected archaeal rDNA. In contrast, the relative abundance
of treponemal rDNA at sites with archaeal rDNA was 6.2 
1.4%; this difference was statistically significant (P  0.05).
There was no significant difference in the relative abundance of
treponemal rDNA found at sites with slight periodontitis or
gingivitis, regardless of whether archaeal rDNA was detected or
not; however, the number of sites with these disease classifica-
tions and detected archaea was small.
Discussion
Members of the domain Archaea are highly diverse in form and
function, but curiously, disease causation is not among their
demonstrated capabilities. We found that the relative abundance
of archaeal SSU rDNA increased in relationship to the severity
of periodontal disease within a cohort of patients. There was a
corresponding decrease in the relative abundance of the archaeal
SSU rDNA coinciding with an improvement in periodontal
status after treatment. The etiology of a polymicrobial disease
such as periodontitis is likely to be more complex than suggested
by the traditional paradigm of disease involving a single virulent
organism. Traditional approaches for establishing causation
require the use of a relevant model system with the presumption
that transfer of a purified microbial isolate will be sufficient to
reproduce disease, as specified in Koch’s postulates. Molecular
criteria have been proposed for imputing a causative role when
the putative factor cannot be easily isolated or purified (29).
Archaea were detected in only a subset of patients with severe
disease. The assay used was capable of detecting amounts of
Archaea representing as little as 0.001% of the prokaryotic
population, suggesting that the methodology was not a limiting
factor in detection. Two hypotheses, which are not mutually
exclusive, may be advanced to explain the presence of oral
methanogens in only a subset of periodontitis patients. The first
hypothesis is that host genetics may predispose some individuals
to colonization by oral methanogens. However, a comparison of
the prevalence of oral and colonic methanogens found that all
individuals harboring oral methanogens also harbored colonic
methanogens, but not vice versa (9), suggesting that host genetics
is not a sufficient explanation for the exclusion of methanogens
from the oral cavity. An additional study of monozygotic and
dizygotic twins found that host genetics did not play a significant
factor in differences in breath methane emission, a hallmark of
colonic methanogens (30).
The second hypothesis proposes niche exclusion of methano-
gens by other hydrogen-metabolizing microbes in some patients.
Sulfate-reducing bacteria (SRB) are potential competitors that
have been reported to be harbored by 	64% of periodontitis
patients, and their presence has been correlated with pocket
depth (31). Under standard conditions, sulfate-reducing bacteria
should out-compete methanogens (32), assuming that the avail-
ability of sulfate is not limited. However, if the interactions
between subgingival SRB and methanogens are similar to those
in the colon, then the two groups may coexist within the same
environment (33, 34). Recent research has indicated that both
may coexist in the oral cavity (13).
Members of the genus Treponema are also potential hydro-
gen competitors, and include a well-known periodontal patho-
gen, Treponema denticola. Previous work has demonstrated that
T. denticola, like Porphyromonas gingivalis and Tannerella for-
sythensis, is associated with severe periodontitis, as a member of
the ‘‘red’’ polymicrobial disease complex (35). It has also recently
been demonstrated that some Treponema species are capable of
homoacetogenesis, a hydrogen-consuming process (36). We
found that the relative abundance of treponemal rDNA was
significantly lower in sites with archaeal rDNA than in sites
without archaeal rDNA, suggesting that some Treponema species
may compete with methanogens. Our results present the possi-
bility that methanogens and treponemes may serve as alternative
syntrophic partners with other members of the subgingival
biofilm community, such as other members of the red complex.
In this scenario, methanogenic Archaea indirectly promote peri-
odontal disease in some patients by serving as a hydrogen sink,
thereby permitting the proliferation of one or more pathogenic
secondary fermenters to levels beyond that which would be
possible in the absence of the archaea.
The apparent restricted diversity exhibited by the oral Archaea
may reflect the adaptation of a small minority of organisms
within this broad domain of life to this particular niche. The
length and morphology of the cells labeled with the Cy-3
archaea-specific polyprobe were consistent with those of Meth-
anobrevibacter oralis. However, the cells observed in this study
were nearly twice the width of those previously reported, which
may reflect differences in growth rate or nutritional status (8).
Members of the genus Methanobrevibacter are strict anaerobes,
Fig. 4. Confocal micrographs of bacteria and archaea in subgingival plaque
from a patient with severe periodontitis. (A) ‘‘Bright field’’ micrograph. (B)
Fluorescent in situ hybridization micrograph of oral archaeum using SBGA-1
Cy-3-labeled polyprobe (pink) and counterstained with the nucleic acid dye
YO-PRO-1 (blue).
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and previous research has shown that mature subgingival plaque
provides the highly reduced environment necessary for anaer-
obic growth (37). Although SBGA-1 was identified in all six of
the patients from which archaeal clone libraries were created,
phylotype SBGA-2 was recovered from only two of the six
patients. Although this latter phylotype appears to be a minor
constituent of the methanogenic population, the number of
patients examined was not large enough to determine the true
distribution of this phylotype.
We speculate that syntrophic interactions between Archaea
and other members of the microbial f lora may be an important
feature of some polymicrobial diseases (4). The identity and role
of the complementary syntrophic partner(s) should provide an
important avenue for future research in eliciting the microbial
mechanisms involved in chronic periodontitis and other polymi-
crobial diseases.
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